Arkolith/Insider Trading/CGEM/Form 4

Michaelson Jennifer

Chief Scientific OfficerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Mar 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$125K
Net Open-Market Flow
-$125K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Option exercise(M)4K$4.30$17K179K
Mar 5, 2026Sell(S)8K$15.68$125K171K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 5, 2026Option exercise(M)4K—$0121K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-098781) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Cullinan Therapeutics, Inc.

Build

Ask your agent about CGEM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-098781"
Ask your agent
Use Arkolith to summarize insider buying and selling at Cullinan Therapeutics, Inc.
over the last 90 days and cite the filings.